Ken Griffin Johnson & Johnson Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $109 Million - $119 Million	-752,400 Reduced 31.26%	1,654,800 $242 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $115 Million - $121 Million	-741,000 Reduced 23.54%	2,407,200 $381 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $184 Million - $201 Million	-1,264,300 Reduced 28.65%	3,148,200 $493 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $275 Million - $308 Million	1,765,900 Added 66.72%	4,412,500 $687 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $64.8 Million - $69.7 Million	-419,800 Reduced 13.69%	2,646,600 $438 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $52 Million - $62 Million	344,000 Added 12.64%	3,066,400 $475 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $16.6 Million - $18.7 Million	-103,800 Reduced 3.67%	2,722,400 $481 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $124 Million - $138 Million	767,400 Added 37.27%	2,826,200 $462 Million

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.